The low chemotherapy response characterising ccRCC and CRC prompted us to investigate whether miR-17-5p and miR-106b-5p might contribute to the chemotherapy resistance due to the TRIM8 protein loss, in the two paradigmatic models of these cancers. This evidence concerns the gene TRIM8 and nonpapillary renal cell carcinoma.